Literature DB >> 34357556

Initial encoding deficits with intact memory retention in older long-term breast cancer survivors.

Alexandra M Gaynor1, Tim A Ahles2, Elizabeth Ryan2, Elizabeth Schofield2, Yuelin Li2, Sunita K Patel3, Katrazyna McNeal2, Tiffany Traina4, James C Root2.   

Abstract

PURPOSE: Cancer survivors frequently report significant forgetfulness, but standard neuropsychological tests often fail to detect primary memory deficits. Past research has suggested survivors may misattribute forgetfulness to memory decay rather than impairments in initial encoding, but no studies have tested whether this pattern is evident in older survivors, who are more vulnerable to age-related memory difficulties. We examined whether long-term breast cancer survivors treated in older adulthood demonstrate deficits in initial encoding, as opposed to increased rates of memory decay, relative to non-cancer controls.
METHODS: Three hundred twenty-eight breast cancer survivors age 60 and above, 5-15 years post-treatment, and 162 age-matched non-cancer controls completed list learning and narrative memory assessments at four time-points over 2 years. Performance on learning trials and delayed recall was analyzed at each time-point to assess group differences in memory encoding, and memory decay was assessed by analyzing changes in performance across delays.
RESULTS: Univariate ANCOVAs correcting for age and education showed that survivors had worse initial encoding performance across multiple time-points, which were compensated for with multiple learning trials to produce recall performance comparable to controls. There were no significant group differences in memory decay.
CONCLUSIONS: Older long-term breast cancer survivors exhibit a consistent pattern of initial encoding deficits, but memory retention was comparable to controls. Future research should consider the role of encoding deficits and age-related factors when evaluating cognitive function in older survivors. IMPLICATIONS FOR CANCER SURVIVORS: Commonly reported memory problems may stem from encoding deficits in older long-term cancer survivors.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Attention; Breast cancer; Cognition; Late effects; Memory

Mesh:

Year:  2021        PMID: 34357556     DOI: 10.1007/s11764-021-01086-8

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.062


  36 in total

1.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.

Authors:  Patricia A Ganz; Lorna Kwan; Steven A Castellon; Amy Oppenheim; Julienne E Bower; Daniel H S Silverman; Steve W Cole; Michael R Irwin; Sonia Ancoli-Israel; Thomas R Belin
Journal:  J Natl Cancer Inst       Date:  2013-04-19       Impact factor: 13.506

2.  Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.

Authors:  Sanne B Schagen; Martin J Muller; Willem Boogerd; Gideon J Mellenbergh; Frits S A M van Dam
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

3.  Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.

Authors:  Michelle C Janelsins; Charles E Heckler; Luke J Peppone; Charles Kamen; Karen M Mustian; Supriya G Mohile; Allison Magnuson; Ian R Kleckner; Joseph J Guido; Kelley L Young; Alison K Conlin; Lora R Weiselberg; Jerry W Mitchell; Christine A Ambrosone; Tim A Ahles; Gary R Morrow
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544

4.  Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer.

Authors:  Val Shilling; Valerie Jenkins
Journal:  Eur J Oncol Nurs       Date:  2006-07-17       Impact factor: 2.398

5.  Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.

Authors:  J Weis; M Poppelreuter; H H Bartsch
Journal:  Psychooncology       Date:  2009-07       Impact factor: 3.894

Review 6.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop.

Authors:  Ian F Tannock; Tim A Ahles; Patricia A Ganz; Frits S Van Dam
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

7.  Examining the Association between Patient-Reported Symptoms of Attention and Memory Dysfunction with Objective Cognitive Performance: A Latent Regression Rasch Model Approach.

Authors:  Yuelin Li; James C Root; Thomas M Atkinson; Tim A Ahles
Journal:  Arch Clin Neuropsychol       Date:  2016-04-24       Impact factor: 2.813

8.  A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

Authors:  V Jenkins; V Shilling; G Deutsch; D Bloomfield; R Morris; S Allan; H Bishop; N Hodson; S Mitra; G Sadler; E Shah; R Stein; S Whitehead; J Winstanley
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

Review 9.  Cognitive Effects of Cancer and Cancer Treatments.

Authors:  Tim A Ahles; James C Root
Journal:  Annu Rev Clin Psychol       Date:  2018-01-18       Impact factor: 22.098

10.  What do cancer patients mean when they complain of concentration and memory problems?

Authors:  A Cull; C Hay; S B Love; M Mackie; E Smets; M Stewart
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.